Scientific Bias Arising from Sampling, Selective Recruitment, and Attrition: The Case for Improved Reporting
Open Access
- 1 March 2011
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 20 (3) , 415-418
Abstract
In human research, the ability to generalize study findings is incumbent not only on an accurate understanding of the study protocol and measures but also on a clear understanding of the study population. Differential recruitment and attrition has the potential of introducing bias and threatening the generalizability of study findings; yet, relatively few scientific publications report data on sampling, subject exclusion, and dropout. A 4-month census sampling (September–December 2009) of research articles and short communications in this journal (n = 116) was no exception. Among articles in which such data were appropriate to report, only 44% documented response rates, 53% described subjects who were excluded, and 10% performed analyses on enrollee versus nonenrollee differences; moreover, of the 17 longitudinal or intervention studies evaluated, only 3 of 17 reported dropout rates, and of those, only 2 of 3 reported reasons for dropout or an analysis that compared the characteristics of dropouts with those of completers. Given Cancer Epidemiology, Biomarkers and Prevention's mission to enhance the dissemination of unbiased scientific findings, we propose that guidelines regarding sample description, as defined by CONSORT, STROBE, or STREGA, be adopted by our journal for both observational and interventional studies that accurately describe the study population from the point of contact. Cancer Epidemiol Biomarkers Prev; 20(3); 415–8. ©2011 AACR.Keywords
This publication has 20 references indexed in Scilit:
- A comparison of the scientific quality of publicly and privately funded randomized controlled drug trialsJournal of Evaluation in Clinical Practice, 2010
- Null Results in Brief: Meeting a Need in Changing TimesCancer Epidemiology, Biomarkers & Prevention, 2009
- STrengthening the REporting of Genetic Association Studies (STREGA)—an extension of the STROBE statementGenetic Epidemiology, 2009
- Diversity of participants in clinical trials in an academic medical centerCancer, 2009
- How much loss to follow-up is acceptable in long-term randomised trials and prospective studies?Archives of Disease in Childhood, 2008
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) StatementEpidemiology, 2007
- The Making of STROBEEpidemiology, 2007
- The quality of randomized trial reporting in leading medical journals since the revised CONSORT statementContemporary Clinical Trials, 2005
- Randomisation and baseline comparisons in clinical trialsThe Lancet, 1990
- Statistical Problems in the Reporting of Clinical TrialsNew England Journal of Medicine, 1987